JournalCompound reference

    Where to Get BPC-157 / TB-500 in the UAE: A Patient Guide

    How the BPC-157 / TB-500 blend is obtained in the UAE: what each peptide is, why a blend needs a two-peptide Certificate of Analysis, and why it belongs with a consultation rather than a search.

    BPC-157 and TB-500 are usually offered as a pair, and that pairing creates a specific problem for anyone trying to source them. A blend has two peptides in one vial, which means twice as many ways to cut a corner and half the chance you will notice. Plenty of listings show a single purity number, or a certificate covering one peptide, and let you assume the other half of the vial is fine.

    This guide covers what BPC-157 and TB-500 each are, why they are used together, the documentation that tells you a blend is real, and why a repair protocol is something to have set for you rather than something you assemble yourself.

    What BPC-157 and TB-500 actually are

    BPC-157 is a synthetic pentadecapeptide, a chain of fifteen amino acids. That sequence is a partial fragment derived from a protein found in gastric juice, which is where the informal name "Body Protection Compound" comes from. In the literature it appears around tendon, ligament, and gut repair signalling.

    TB-500 is a synthetic version of an active fragment of Thymosin Beta-4, a peptide that occurs naturally in the body and plays a role in actin regulation and cell migration. Where BPC-157 sits closer to local repair signalling, TB-500 sits closer to how cells move and how new blood vessels form.

    The reason the two are combined is that they act through complementary pathways rather than the same one. Together they cover ground neither covers alone, which is the rationale behind putting them in a single pen. We go deeper on the mechanics in the BPC-157 vs TB-500 comparison.

    Why a repair protocol is a decision, not a purchase

    Neither peptide is an approved medicine, and the human evidence base is thinner than the internet suggests, much of what gets quoted confidently comes from animal and in-vitro work. That is not a reason to dismiss them, but it is a reason not to self-administer them.

    There is also a more practical point that gets skipped. Pain and poor healing have causes, and some of those causes get worse if you mask them or train through them. A tendon that is not healing may be a tendon that is being loaded wrong, or a symptom of something systemic. Starting a repair peptide without anyone establishing what is actually wrong is how people spend eight weeks and a lot of money on the wrong problem. A proper assessment starts by asking what the injury actually is.

    The two things that decide whether a vial is what it claims

    Two questions decide whether a batch is usable. Is it pure, and is it actually what the label says? With a blend, that second question doubles: you need both BPC-157 and TB-500 confirmed present, rather than one of them padded out with the other.

    Purity comes from high performance liquid chromatography (), which separates everything in the sample and reports each fraction as a percentage. Identity comes from (MS), which weighs the molecule and confirms it matches the expected peptide. For a blend, a proper CoA shows both peptides accounted for, each with its own purity and identity data, so you can see the ratio and confirm neither was quietly left out.

    How to read a blend CoA in under a minute

    A (CoA) is the lab report for one production batch, and you are entitled to see it. For a two-peptide blend, look for these:

    • A batch or lot number that matches the vial in front of you. A generic CoA for "BPC-157 / TB-500" in the abstract is not a CoA for your material.
    • HPLC purity for both peptides, each stated as a percentage. One number for the blend as a whole hides which peptide is carrying it.
    • Mass spectrometry confirming both identities. This is the half that proves both compounds are actually in the vial.
    • A test date. A CoA reused across every batch for years is a paperwork exercise, not verification.
    • The testing lab's name. Independent, third-party testing means a lab with no stake in the result did the work.

    The name that comes up most in this space is Janoshik Analytical, a European lab used widely because its reports can be checked through its own portal. Your consultant can show you the Janoshik report for the specific batch in your program.

    PUBLISHED BATCH CERTIFICATEJanoshik Analytical
    COMPOUNDBPC157 & TB500 32 Pen
    BATCH NºBCTB0178must match your pen
    HPLC PURITY99.13% / 99.36%≥98% is the floor
    TEST DATE32mg pen 3mlthis batch, recent

    Storage, and why it is not your problem to solve

    The blend is supplied lyophilised, freeze-dried into a small pellet or film. In that state it is reasonably stable, but it is not indestructible. Unopened vials belong at 2 to 8 degrees Celsius and out of the light. Once reconstituted, refrigerated and used within a few weeks.

    Material that spends two days on a hot courier dashboard is how a strong CoA turns into nothing much at all, and in UAE conditions that is a real risk, not a theoretical one. The cold chain either exists or it does not, and the packaging will not tell you which.

    Grey-market signals worth walking away from

    • No Certificate of Analysis, or vague "lab tested" wording with nothing you can actually read.
    • A CoA that covers only one of the two peptides, or reports a single blended purity figure with no per-peptide breakdown.
    • A CoA missing a batch number, a date, or the testing lab's name.
    • Dosing instructions for humans from a seller with no clinician involved.
    • Confident claims about healing outcomes that the human evidence does not support.
    • A price dramatically below everyone else with no explanation for it.
    • A seller you cannot actually reach, with no traceable business details.

    How this works at Baseline

    Baseline is a consultation-led service, not a shop. You do not buy this blend here and we do not ship it to you on request.

    You complete a short assessment, your consultant reads your injury history, imaging if you have it, and anything else you are taking, and you have a consultation. Part of that conversation is whether a repair peptide is the right tool at all, or whether what you actually need is a diagnosis, rehab loading, or something else entirely. If a protocol is appropriate it is set out, dosed and monitored over a defined course.

    Every batch carries independent Janoshik documentation, and your consultant will show you the report for the batch you are given. You can see who you will be speaking to before you book. The consultation is AED 350, credited against your program if you go ahead.


    This article is educational and is not a diagnosis, a treatment plan, or a recommendation to use any specific compound. Neither BPC-157 nor TB-500 is an approved medicine. A consultation decides what is appropriate for you.

    Frequently asked questions

    Next step

    Find out whether this is appropriate for you

    Reading is not a diagnosis. A consultation goes through your history with you and tells you plainly whether a program fits, including when it does not. AED 350, credited in full against your first order.